AVEO Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech (Jan. 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
Article By: Benzinga
Saturday, January 9, 2021 2:32 PM EDT
After ending 2020 in the green, biotech stocks had a strong start to 2021, partly capitalizing on the broader strength markets saw this past week despite political turmoil at Capitol Hill. The week witnessed some strong moves in momentum stocks.
In this article: AZN, JPM, AVEO, MRNA, SRPT, FPRX, JAGX, ZYME, ZLAB, RCUS
Read
Hardest To Borrow
Article By: Interactive Brokers
Wednesday, July 19, 2017 5:14 PM EDT
We have selected the 15 hardest to borrow securities during the week of 7/12/17 - 7/18/17.
In this article: PDT, CRF, AVEO, ZN, BONT, SPEX, RH, CARA, AAOI, CDNA, ANY, XGTI
Read
Biotech Stock Roundup: EU Nod For Regeneron RA Drug, Portola Soars On FDA Nod
Article By: Arpita Dutt
Thursday, June 29, 2017 9:44 AM EDT
Biotech stocks have been in the news recently with expectations remaining high that steps taken by the Trump administration to drive down drug prices will not be as draconian as previously expected.
In this article: PTLA, REGN, AVEO, GILD, ABBV, ALNY, BIIB
Read
Week In Review: Origin-Centrillion Offers $1.5 Billion For Affymetrix
Article By: ChinaBio® Today
Saturday, March 26, 2016 4:16 PM EDT
Origin Technologies, a US company with deep China connections, has raised its bid to acquire Affymetrix, a US microarray company, to $17 per share.
In this article: AFFX Also: TSRO, TMO, AVEO
Read
All Posts

Latest Tweets for $AVEO

No tweets yet!

PARTNER HEADLINES